# Module 12: AI & Machine Learning in Hepatitis Diagnosis

> **Reference**: *Indonesian Journal of Computer Science*, Vol. 13, No. 3, 2024. ISSN: 2549-7286.

## 1. Introduction
Modern hepatology is increasingly leveraging Machine Learning (ML) to improve the accuracy, speed, and cost-effectiveness of hepatitis diagnosis. By analyzing clinical and laboratory findings (like age, gender, bilirubin, albumin, etc.), ML models can predict disease presence, severity, and patient outcomes.

---

## 2. Core Algorithms & Methodology

| Algorithm | Description | Performance Highlights |
| :--- | :--- | :--- |
| **Random Forest (RF)** | An ensemble method combining multiple decision trees. Handles complex interactions well. | Achieved **99.9% accuracy** in some UCI datasets; 94.06% in Egyptian HCV studies. |
| **Naive Bayes (NB)** | Probabilistic model based on Bayes' Theorem. Simple and scalable for real-time diagnostics. | Achieved ~90% accuracy; effective for early patient stratification. |
| **K-Nearest Neighbors (KNN)** | Classifies based on the similarity of feature vectors. | Accuracy varies (89.43% to 98.1%) depending on the value of 'K'. |
| **Support Vector Machines (SVM)** | Effective in high-dimensional spaces using kernel functions (Gaussian/Linear). | Gaussian RBF kernel reached **99.55% accuracy**. |
| **Artificial Neural Networks (ANN)** | Mimics biological neural processing. | High performance with ~96% accuracy and minimal Mean Square Error. |

---

## 3. Key Optimization Techniques
To reach high accuracy (90%+), researchers employ several critical preprocessing and optimization steps:

### A. Feature Selection
*   **Sequential Forward Selection (SFS)**: Identifies the most relevant diagnostic traits (e.g., specific blood markers).
*   **Ranker Search & Info-Gain**: Reduces dimensionality to focus on the most impactful data points.

### B. Data Imbalance & Missing Values
*   **SMOTE (Synthetic Minority Over-sampling Technique)**: Balances datasets where infected cases are much fewer than healthy cases.
*   **Mean/Mode Imputation**: Filling in missing clinical data to ensure model robustness.

### C. Hyperparameter Optimization
*   **Particle Swarm Optimization (PSO)**: Used to find the optimal 'K' in KNN, improving accuracy by ~2%.
*   **Random Search**: Tuning neural network parameters to boost performance beyond default settings.

---

## 4. Clinical Significance
*   **Early Detection**: ML allows for identification of hepatitis stages before severe symptoms manifest.
*   **Personalized Treatment**: By uncovering key diagnostic traits, these models help doctors choose tailored intervention strategies.
*   **Scalability**: High-throughput diagnostic tools enable screening in resource-limited environments.

---
[Back to Syllabus](../SYLLABUS.md)

---

## ğŸŒŸ çµ¦å°ç™½çš„ AI æ¼”ç®—æ³•å¤§ç™½è©±æŒ‡å—

å¦‚æœæŠŠã€Œè¨ºæ–·è‚ç‚ã€æ¯”å–»æˆä¸€å ´**é†«ç”Ÿæœƒè¨º**ï¼Œé€™äº”ç¨®æ¼”ç®—æ³•å°±åƒäº”ä½é¢¨æ ¼è¿¥ç•°çš„å°ˆå®¶ï¼š

### 1. éš¨æ©Ÿæ£®æ— (Random Forest, RF) â€”â€” ã€Œå°ˆå®¶é™ªå¯©åœ˜ã€
*   **æ€éº¼é‹ä½œ**ï¼šæƒ³åƒä½ æœ‰ 100 å€‹é†«ç”Ÿï¼Œæ¯å€‹é†«ç”Ÿéƒ½åªçœ‹ç—…äººçš„ä¸€å°éƒ¨åˆ†ç—‡ç‹€ï¼ˆæ¯”å¦‚ A é†«ç”Ÿçœ‹å¹´é½¡ï¼ŒB é†«ç”Ÿçœ‹è†½ç´…ç´ ï¼‰ã€‚æœ€å¾Œï¼Œé€™ 100 å€‹é†«ç”ŸæŠ•ç¥¨ï¼Œç¥¨æ•¸æœ€å¤šçš„è¨ºæ–·çµæœå°±æ˜¯æœ€çµ‚ç­”æ¡ˆã€‚
*   **ç‚ºä»€éº¼å²å®³**ï¼šå› ç‚ºå®ƒæ˜¯ã€Œç¾¤çœ¾çš„æ™ºæ…§ã€ã€‚å°±ç®—å…¶ä¸­ä¸€å…©å€‹é†«ç”Ÿçœ‹èµ°çœ¼ï¼Œæ•´é«”çš„æº–ç¢ºåº¦ï¼ˆæœ€é«˜é” 99.9%ï¼‰ä¾ç„¶éå¸¸ç©©å¥ã€‚

### 2. è²æ°åˆ†é¡å™¨ (Naive Bayes, NB) â€”â€” ã€Œç®—å‘½å¤§å¸«ï¼ˆæ©Ÿç‡æ´¾ï¼‰ã€
*   **æ€éº¼é‹ä½œ**ï¼šå®ƒæœƒæ ¹æ“šæ­·å²æ•¸æ“šç®—æ©Ÿç‡ã€‚æ¯”å¦‚ï¼šã€Œæ­·å²ä¸Šï¼Œçœ¼ç™½ç™¼é»ƒä¸” ALT æ•¸å€¼é«˜çš„äººï¼Œæœ‰ 90% æ˜¯è‚ç‚ã€ã€‚å®ƒæœƒæŠŠæ‰€æœ‰ç—‡ç‹€å‡ºç¾çš„æ©Ÿç‡ä¹˜èµ·ä¾†ï¼Œç®—å‡ºä½ æ˜¯è‚ç‚çš„ã€Œå‹ç®—ã€æœ‰å¤šå°‘ã€‚
*   **ç‚ºä»€éº¼å²å®³**ï¼šå®ƒåæ‡‰æ¥µå¿«ï¼Œé©åˆè™•ç†å¤§é‡æ•¸æ“šï¼Œé›–ç„¶å®ƒå‡è¨­å„å€‹ç—‡ç‹€ä¹‹é–“äº’ä¸ç›¸é—œï¼ˆé€™é»å¾ˆã€Œå¤©çœŸ/Naiveã€ï¼‰ï¼Œä½†åœ¨ç¾å¯¦ä¸­å¾€å¾€å‡ºå¥‡åœ°æº–ã€‚

### 3. K-è¿‘é„°æ¼”ç®—æ³• (K-Nearest Neighbors, KNN) â€”â€” ã€Œç‰©ä»¥é¡èšã€
*   **æ€éº¼é‹ä½œ**ï¼šé€™å°±æ˜¯ã€Œçœ‹ä½ çš„æœ‹å‹æ˜¯èª°ï¼Œå°±çŸ¥é“ä½ æ˜¯èª°ã€ã€‚AI æœƒæŠŠæ‰€æœ‰ç—…äººçš„æ•¸æ“šç•«åœ¨ä¸€å€‹åœ°åœ–ä¸Šã€‚ç•¶ä¸€å€‹æ–°ç—…äººé€²ä¾†æ™‚ï¼ŒAI çœ‹ä»–èº«é‚Šæœ€è¿‘çš„ K å€‹ï¼ˆæ¯”å¦‚ 5 å€‹ï¼‰ã€Œé„°å±…ã€æ˜¯èª°ã€‚å¦‚æœé„°å±…å¤§éƒ½æ˜¯è‚ç‚æ‚£è€…ï¼Œé‚£é€™å€‹ç—…äººæ¥µå¤§æ©Ÿç‡ä¹Ÿæ˜¯ã€‚
*   **ç‚ºä»€éº¼å²å®³**ï¼šéå¸¸ç›´è§€ï¼Œä¸éœ€è¦è¤‡é›œçš„è¨“ç·´éç¨‹ï¼Œåªè¦æ•¸æ“šå¤ å¤šï¼Œå®ƒå°±èƒ½åƒè€ä¸­é†«ä¸€æ¨£æ†‘ã€Œæ—¢è¦–æ„Ÿã€è¨ºæ–·ã€‚

### 4. æ”¯æŒå‘é‡æ©Ÿ (Support Vector Machines, SVM) â€”â€” ã€Œæ¥šæ²³æ¼¢ç•Œã€
*   **æ€éº¼é‹ä½œ**ï¼šå®ƒæ˜¯ä¸€ä½ã€Œç•«ç·šé«˜æ‰‹ã€ã€‚å®ƒè©¦åœ–åœ¨å¥åº·çš„äººå’Œç”Ÿç—…çš„äººä¹‹é–“ï¼Œç•«å‡ºä¸€æ¢æœ€å¯¬ã€æœ€æ˜é¡¯çš„ã€Œåˆ†ç•Œç·šã€ã€‚å¦‚æœæœ‰äººçš„æ•¸æ“šè½åœ¨ç·šçš„å·¦é‚Šå°±æ˜¯å¥åº·ï¼Œå³é‚Šå°±æ˜¯ç”Ÿç—…ã€‚
*   **ç‚ºä»€éº¼å²å®³**ï¼šå®ƒéå¸¸æ“…é•·è™•ç†ã€Œéé»‘å³ç™½ã€çš„åˆ†é¡å•é¡Œï¼Œç‰¹åˆ¥æ˜¯åœ¨æ•¸æ“šç¶­åº¦éå¸¸è¤‡é›œï¼ˆæ¯”å¦‚åŒæ™‚è€ƒæ…®å¹¾åç¨®è¡€æ¶²æŒ‡æ¨™ï¼‰æ™‚ï¼Œå®ƒèƒ½æ‰¾åˆ°é‚£æ¢æœ€å®Œç¾çš„ç•Œç·šã€‚

### 5. äººå·¥ç¥ç¶“ç¶²è·¯ (Artificial Neural Networks, ANN) â€”â€” ã€Œè¶…ç´šå¤§è…¦ã€
*   **æ€éº¼é‹ä½œ**ï¼šå®ƒæ¨¡ä»¿äººé¡å¤§è…¦ç¥ç¶“å…ƒçš„é€£æ¥æ–¹å¼ã€‚æ•¸æ“šæœƒç¶“éä¸€å±¤åˆä¸€å±¤çš„ã€Œç¥ç¶“å…ƒã€è™•ç†ï¼Œæ¯ä¸€å±¤éƒ½æœƒæ•æ‰ä¸€äº›è‚‰çœ¼çœ‹ä¸è¦‹çš„ç´°å¾®ç‰¹å¾µï¼ˆæ¯”å¦‚å¹´é½¡å’ŒæŸç¨®è›‹ç™½è³ªæŒ‡æ¨™çš„å¾®å¦™æ¯”ä¾‹ï¼‰ã€‚
*   **ç‚ºä»€éº¼å²å®³**ï¼šå®ƒæ˜¯ç›®å‰ AI çš„ä¸»æµï¼Œæ“…é•·è™•ç†æ¥µå…¶è¤‡é›œã€äººé¡é†«ç”Ÿä¹Ÿé›£ä»¥ç¸½çµè¦å¾‹çš„éš±è—ç‰¹å¾µï¼Œæº–ç¢ºç‡æ¥µé«˜ã€‚

